Daniel F J Ketelhuth Selected Research

Cholesterol

6/2022	Animal Models of Atherosclerosis-Supportive Notes and Tricks of the Trade.
5/2022	Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model.
6/2021	Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.
12/2019	Quantification of Atherosclerosis in Mice.
1/2019	Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology.
11/2018	Low-Density Lipoprotein-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice.
2/2016	Adaptive Response of T and B Cells in Atherosclerosis.
4/2015	Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response.
7/2013	Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.
1/2013	T cell-based therapies for atherosclerosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel F J Ketelhuth Research Topics

Disease

38	Atherosclerosis 05/2022 - 01/2002
21	Inflammation (Inflammations) 06/2022 - 03/2011
11	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 01/2008
6	Atherosclerotic Plaque (Atheroma) 01/2019 - 04/2011
4	Thrombosis (Thrombus) 01/2019 - 03/2010
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2015
2	Neoplasms (Cancer) 01/2019 - 01/2018
2	Rupture 01/2018 - 03/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 03/2004
2	Hypercholesterolemia 11/2017 - 05/2017
2	Myocardial Infarction 01/2016 - 03/2010
2	Obesity 10/2015 - 06/2013
2	Stroke (Strokes) 01/2015 - 03/2010
2	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 08/2012
1	Non-alcoholic Fatty Liver Disease 05/2022
1	Hepatocellular Carcinoma (Hepatoma) 05/2022
1	Liver Diseases (Liver Disease) 05/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Adenoviridae Infections (Adenovirus Infections) 10/2020
1	Hyperplasia 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Aneurysm (Aneurysms) 01/2019
1	Disease Progression 10/2018
1	ST Elevation Myocardial Infarction 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Infections 01/2016
1	Insulin Resistance 10/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015
1	Rheumatoid Arthritis 01/2015

Drug/Important Bio-Agent (IBA)

11	CholesterolIBA 06/2022 - 05/2012
10	Lipoproteins (Lipoprotein)IBA 06/2022 - 07/2006
9	LipidsIBA 10/2020 - 04/2011
8	Proteins (Proteins, Gene)FDA Link 11/2018 - 01/2002
8	LDL Lipoproteins (beta Lipoproteins)IBA 11/2018 - 05/2010
8	oxidized low density lipoproteinIBA 11/2018 - 01/2002
7	Apolipoproteins E (ApoE)IBA 05/2022 - 05/2015
5	ApolipoproteinsIBA 06/2022 - 03/2011
5	KynurenineIBA 05/2022 - 01/2019
4	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2022 - 05/2015
4	CytokinesIBA 01/2022 - 03/2011
4	AntibodiesIBA 01/2019 - 03/2004
4	LDL Receptors (LDL Receptor)IBA 05/2017 - 07/2006
3	Tryptophan (L-Tryptophan)FDA Link 10/2020 - 08/2012
3	3-Hydroxyanthranilic AcidIBA 10/2020 - 08/2012
3	Apolipoprotein B-100 (Apo B 100)IBA 11/2018 - 05/2010
3	Matrix Metalloproteinases (MMPs)IBA 09/2015 - 03/2010
3	AntigensIBA 06/2013 - 05/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2015
2	InterferonsIBA 01/2022 - 07/2013
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2011
2	low density lipoprotein inhibitorIBA 01/2018 - 01/2013
2	Biological ProductsIBA 01/2017 - 03/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2016 - 05/2012
2	AutoantigensIBA 02/2016 - 04/2015
2	Phosphorylcholine (Phosphocholine)IBA 01/2016 - 04/2015
2	Glucose (Dextrose)FDA LinkGeneric 10/2015 - 06/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2015 - 07/2013
2	EpitopesIBA 04/2015 - 05/2010
2	Triglycerides (Triacylglycerol)IBA 05/2012 - 01/2002
2	Peptides (Polypeptides)IBA 11/2011 - 05/2010
1	IronIBA 05/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	AngiotensinsIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	Inflammation MediatorsIBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	RotenoneIBA 10/2020
1	AcidsIBA 10/2020
1	InflammasomesIBA 10/2020
1	I-kappa B KinaseIBA 01/2020
1	NF-kappaB-Inducing KinaseIBA 01/2020
1	Pharmaceutical PreparationsIBA 12/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	EnzymesIBA 01/2019
1	Pancreatic Elastase (Elastase)IBA 01/2019
1	canakinumab FDA Link 01/2019
1	Fc Receptors (Fc Receptor)IBA 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 10/2018
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 10/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2017
1	Immunoglobulin M (IgM)IBA 01/2016
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2016
1	DNA Glycosylases (DNA Glycosylase)IBA 01/2016
1	DNA Repair EnzymesIBA 01/2016
1	Insulin (Novolin)FDA Link 10/2015
1	Leukotriene B4IBA 09/2015
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 09/2015
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2015

Therapy/Procedure

5	Therapeutics 06/2022 - 01/2013
1	Secondary Prevention 01/2019
1	Percutaneous Coronary Intervention 01/2018
1	Glycemic Control 10/2015